awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36054501-C856A546-4E05-4451-A158-B0B843B406D1
Q36054501-C856A546-4E05-4451-A158-B0B843B406D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36054501-C856A546-4E05-4451-A158-B0B843B406D1
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
P2860
Q36054501-C856A546-4E05-4451-A158-B0B843B406D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36054501-C856A546-4E05-4451-A158-B0B843B406D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b0fca63d14b105d2db09dfbe6cdb4c18dfedb72c
P2860
Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.